nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CALM1—type 2 diabetes mellitus	0.155	0.418	CbGaD
Perphenazine—ADRA2A—type 2 diabetes mellitus	0.07	0.189	CbGaD
Perphenazine—HTR2C—type 2 diabetes mellitus	0.0644	0.174	CbGaD
Perphenazine—CYP1A2—type 2 diabetes mellitus	0.0486	0.131	CbGaD
Perphenazine—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0329	0.0819	CbGbCtD
Perphenazine—CYP3A4—type 2 diabetes mellitus	0.0322	0.087	CbGaD
Perphenazine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0253	0.0632	CbGbCtD
Perphenazine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0222	0.0554	CbGbCtD
Perphenazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0177	0.044	CbGbCtD
Perphenazine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0129	0.0322	CbGbCtD
Perphenazine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0122	0.0305	CbGbCtD
Perphenazine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0122	0.0304	CbGbCtD
Perphenazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0116	0.029	CbGbCtD
Perphenazine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0116	0.029	CbGbCtD
Perphenazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0107	0.0267	CbGbCtD
Perphenazine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00977	0.0244	CbGbCtD
Perphenazine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00884	0.022	CbGbCtD
Perphenazine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00872	0.0217	CbGbCtD
Perphenazine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00853	0.0213	CbGbCtD
Perphenazine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00816	0.0203	CbGbCtD
Perphenazine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00788	0.0196	CbGbCtD
Perphenazine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0078	0.0194	CbGbCtD
Perphenazine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00742	0.0185	CbGbCtD
Perphenazine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00742	0.0185	CbGbCtD
Perphenazine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00725	0.0181	CbGbCtD
Perphenazine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00684	0.0171	CbGbCtD
Perphenazine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00661	0.0165	CbGbCtD
Perphenazine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00642	0.016	CbGbCtD
Perphenazine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00632	0.0157	CbGbCtD
Perphenazine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00617	0.0154	CbGbCtD
Perphenazine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00617	0.0154	CbGbCtD
Perphenazine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00569	0.0142	CbGbCtD
Perphenazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00564	0.0141	CbGbCtD
Perphenazine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00556	0.0139	CbGbCtD
Perphenazine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0055	0.0137	CbGbCtD
Perphenazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0052	0.013	CbGbCtD
Perphenazine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00503	0.0125	CbGbCtD
Perphenazine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00497	0.0124	CbGbCtD
Perphenazine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00496	0.0124	CbGbCtD
Perphenazine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0047	0.0117	CbGbCtD
Perphenazine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00467	0.0116	CbGbCtD
Perphenazine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00454	0.0113	CbGbCtD
Perphenazine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00448	0.0112	CbGbCtD
Perphenazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00427	0.0106	CbGbCtD
Perphenazine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00414	0.0103	CbGbCtD
Perphenazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0041	0.0102	CbGbCtD
Perphenazine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00396	0.00988	CbGbCtD
Perphenazine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0038	0.00946	CbGbCtD
Perphenazine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00359	0.00894	CbGbCtD
Perphenazine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00347	0.00865	CbGbCtD
Perphenazine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0032	0.00799	CbGbCtD
Perphenazine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00316	0.00787	CbGbCtD
Perphenazine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00289	0.0072	CbGbCtD
Perphenazine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00272	0.00677	CbGbCtD
Perphenazine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0026	0.00649	CbGbCtD
Perphenazine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0026	0.00649	CbGbCtD
Perphenazine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00246	0.00614	CbGbCtD
Perphenazine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00188	0.0496	CbGeAlD
Perphenazine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00184	0.0485	CbGeAlD
Perphenazine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00184	0.00457	CbGbCtD
Perphenazine—HTR2A—arteriole—type 2 diabetes mellitus	0.0018	0.0474	CbGeAlD
Perphenazine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00168	0.00418	CbGbCtD
Perphenazine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.00126	0.0334	CbGeAlD
Perphenazine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00123	0.0326	CbGeAlD
Perphenazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00114	0.0302	CbGeAlD
Perphenazine—DRD1—nerve—type 2 diabetes mellitus	0.00111	0.0293	CbGeAlD
Perphenazine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.000915	0.0242	CbGeAlD
Perphenazine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.000911	0.0241	CbGeAlD
Perphenazine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00089	0.0235	CbGeAlD
Perphenazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000769	0.0203	CbGeAlD
Perphenazine—CALM2—artery—type 2 diabetes mellitus	0.000719	0.019	CbGeAlD
Perphenazine—CALM1—artery—type 2 diabetes mellitus	0.000716	0.0189	CbGeAlD
Perphenazine—CALM2—nerve—type 2 diabetes mellitus	0.000714	0.0188	CbGeAlD
Perphenazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000712	0.0188	CbGeAlD
Perphenazine—CALM1—nerve—type 2 diabetes mellitus	0.00071	0.0188	CbGeAlD
Perphenazine—HTR7—artery—type 2 diabetes mellitus	0.0007	0.0185	CbGeAlD
Perphenazine—HTR7—nerve—type 2 diabetes mellitus	0.000694	0.0183	CbGeAlD
Perphenazine—DRD2—nerve—type 2 diabetes mellitus	0.000656	0.0173	CbGeAlD
Perphenazine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000653	0.0172	CbGeAlD
Perphenazine—CALM2—endothelium—type 2 diabetes mellitus	0.000608	0.016	CbGeAlD
Perphenazine—CALM1—endothelium—type 2 diabetes mellitus	0.000605	0.016	CbGeAlD
Perphenazine—HTR7—endothelium—type 2 diabetes mellitus	0.000591	0.0156	CbGeAlD
Perphenazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000555	0.0147	CbGeAlD
Perphenazine—AOX1—islet of Langerhans—type 2 diabetes mellitus	0.000489	0.0129	CbGeAlD
Perphenazine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.00044	0.0116	CbGeAlD
Perphenazine—HTR2A—artery—type 2 diabetes mellitus	0.000436	0.0115	CbGeAlD
Perphenazine—HTR2A—nerve—type 2 diabetes mellitus	0.000433	0.0114	CbGeAlD
Perphenazine—AOX1—nephron tubule—type 2 diabetes mellitus	0.000394	0.0104	CbGeAlD
Perphenazine—CALM3—retina—type 2 diabetes mellitus	0.000376	0.00994	CbGeAlD
Perphenazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000369	0.00973	CbGeAlD
Perphenazine—CALM3—nephron tubule—type 2 diabetes mellitus	0.000354	0.00936	CbGeAlD
Perphenazine—AOX1—kidney—type 2 diabetes mellitus	0.000346	0.00913	CbGeAlD
Perphenazine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000346	0.00913	CbGeAlD
Perphenazine—CYP2C18—liver—type 2 diabetes mellitus	0.000345	0.00912	CbGeAlD
Perphenazine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000344	0.00909	CbGeAlD
Perphenazine—AOX1—pancreas—type 2 diabetes mellitus	0.000344	0.00907	CbGeAlD
Perphenazine—AOX1—cortex of kidney—type 2 diabetes mellitus	0.000337	0.0089	CbGeAlD
Perphenazine—AOX1—adipose tissue—type 2 diabetes mellitus	0.000312	0.00823	CbGeAlD
Perphenazine—CALM3—pancreas—type 2 diabetes mellitus	0.000309	0.00817	CbGeAlD
Perphenazine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000303	0.00801	CbGeAlD
Perphenazine—CALM2—retina—type 2 diabetes mellitus	0.000296	0.00781	CbGeAlD
Perphenazine—CALM1—retina—type 2 diabetes mellitus	0.000294	0.00777	CbGeAlD
Perphenazine—CALM3—adipose tissue—type 2 diabetes mellitus	0.000281	0.00741	CbGeAlD
Perphenazine—CALM2—nephron tubule—type 2 diabetes mellitus	0.000278	0.00735	CbGeAlD
Perphenazine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000277	0.00732	CbGeAlD
Perphenazine—DRD2—retina—type 2 diabetes mellitus	0.000272	0.00718	CbGeAlD
Perphenazine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000254	0.00672	CbGeAlD
Perphenazine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.00025	0.0066	CbGeAlD
Perphenazine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000249	0.00657	CbGeAlD
Perphenazine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000247	0.00651	CbGeAlD
Perphenazine—CALM2—kidney—type 2 diabetes mellitus	0.000245	0.00646	CbGeAlD
Perphenazine—CALM1—kidney—type 2 diabetes mellitus	0.000243	0.00643	CbGeAlD
Perphenazine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000243	0.00642	CbGeAlD
Perphenazine—CALM2—pancreas—type 2 diabetes mellitus	0.000243	0.00642	CbGeAlD
Perphenazine—CALM1—pancreas—type 2 diabetes mellitus	0.000242	0.00639	CbGeAlD
Perphenazine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000238	0.00629	CbGeAlD
Perphenazine—HTR7—kidney—type 2 diabetes mellitus	0.000238	0.00628	CbGeAlD
Perphenazine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000237	0.00626	CbGeAlD
Perphenazine—CALM2—adipose tissue—type 2 diabetes mellitus	0.00022	0.00582	CbGeAlD
Perphenazine—CALM1—adipose tissue—type 2 diabetes mellitus	0.000219	0.0058	CbGeAlD
Perphenazine—AOX1—liver—type 2 diabetes mellitus	0.000219	0.00577	CbGeAlD
Perphenazine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000207	0.00547	CbGeAlD
Perphenazine—CYP2C8—kidney—type 2 diabetes mellitus	0.000203	0.00535	CbGeAlD
Perphenazine—CALM3—liver—type 2 diabetes mellitus	0.000197	0.0052	CbGeAlD
Perphenazine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000186	0.00491	CbGeAlD
Perphenazine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000184	0.00486	CbGeAlD
Perphenazine—CYP2B6—kidney—type 2 diabetes mellitus	0.000182	0.0048	CbGeAlD
Perphenazine—HTR2A—retina—type 2 diabetes mellitus	0.000179	0.00473	CbGeAlD
Perphenazine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000173	0.00458	CbGeAlD
Perphenazine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.00017	0.00449	CbGeAlD
Perphenazine—HRH1—adipose tissue—type 2 diabetes mellitus	0.00016	0.00423	CbGeAlD
Perphenazine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000157	0.00415	CbGeAlD
Perphenazine—CALM2—liver—type 2 diabetes mellitus	0.000155	0.00408	CbGeAlD
Perphenazine—CALM1—liver—type 2 diabetes mellitus	0.000154	0.00406	CbGeAlD
Perphenazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000152	0.004	CbGeAlD
Perphenazine—HTR7—liver—type 2 diabetes mellitus	0.00015	0.00397	CbGeAlD
Perphenazine—HTR2A—kidney—type 2 diabetes mellitus	0.000148	0.00392	CbGeAlD
Perphenazine—CYP2C19—liver—type 2 diabetes mellitus	0.000147	0.00388	CbGeAlD
Perphenazine—CYP3A4—kidney—type 2 diabetes mellitus	0.000137	0.00363	CbGeAlD
Perphenazine—CYP2D6—kidney—type 2 diabetes mellitus	0.000135	0.00357	CbGeAlD
Perphenazine—CYP2C8—liver—type 2 diabetes mellitus	0.000128	0.00338	CbGeAlD
Perphenazine—Shock—Bromocriptine—type 2 diabetes mellitus	0.000121	0.00119	CcSEcCtD
Perphenazine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Perphenazine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Perphenazine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Perphenazine—CYP1A2—liver—type 2 diabetes mellitus	0.00012	0.00317	CbGeAlD
Perphenazine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00118	CcSEcCtD
Perphenazine—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Perphenazine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Perphenazine—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000119	0.00117	CcSEcCtD
Perphenazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000118	0.0399	CrCbGaD
Perphenazine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000118	0.00117	CcSEcCtD
Perphenazine—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000118	0.00117	CcSEcCtD
Perphenazine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000118	0.00117	CcSEcCtD
Perphenazine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000118	0.00116	CcSEcCtD
Perphenazine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000117	0.00116	CcSEcCtD
Perphenazine—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000117	0.00116	CcSEcCtD
Perphenazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Perphenazine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Perphenazine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Perphenazine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Perphenazine—CYP2B6—liver—type 2 diabetes mellitus	0.000115	0.00304	CbGeAlD
Perphenazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000115	0.00113	CcSEcCtD
Perphenazine—Jaundice—Losartan—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Perphenazine—CYP2C9—liver—type 2 diabetes mellitus	0.000114	0.00301	CbGeAlD
Perphenazine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Perphenazine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Perphenazine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000113	0.00112	CcSEcCtD
Perphenazine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000113	0.00112	CcSEcCtD
Perphenazine—Asthma—Ramipril—type 2 diabetes mellitus	0.000113	0.00112	CcSEcCtD
Perphenazine—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000113	0.00112	CcSEcCtD
Perphenazine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000113	0.00112	CcSEcCtD
Perphenazine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000112	0.00111	CcSEcCtD
Perphenazine—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Perphenazine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Perphenazine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Perphenazine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Perphenazine—Headache—Repaglinide—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Perphenazine—Shock—Glyburide—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Perphenazine—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Perphenazine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Perphenazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000109	0.00108	CcSEcCtD
Perphenazine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000109	0.00108	CcSEcCtD
Perphenazine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000109	0.00108	CcSEcCtD
Perphenazine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000109	0.00108	CcSEcCtD
Perphenazine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Perphenazine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Perphenazine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Perphenazine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Perphenazine—Cough—Gliclazide—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Perphenazine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Perphenazine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Perphenazine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Perphenazine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Perphenazine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Perphenazine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000107	0.00105	CcSEcCtD
Perphenazine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000106	0.00105	CcSEcCtD
Perphenazine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Perphenazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Perphenazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Perphenazine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Perphenazine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000104	0.00103	CcSEcCtD
Perphenazine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Perphenazine—Erythema—Metformin—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Perphenazine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Perphenazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Perphenazine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Perphenazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Perphenazine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000102	0.00101	CcSEcCtD
Perphenazine—Syncope—Valsartan—type 2 diabetes mellitus	0.000102	0.00101	CcSEcCtD
Perphenazine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000101	0.001	CcSEcCtD
Perphenazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.0001	0.0339	CrCbGaD
Perphenazine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.0001	0.000991	CcSEcCtD
Perphenazine—Infection—Gliclazide—type 2 diabetes mellitus	9.99e-05	0.00099	CcSEcCtD
Perphenazine—Dyspnoea—Glyburide—type 2 diabetes mellitus	9.99e-05	0.000989	CcSEcCtD
Perphenazine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	9.98e-05	0.000988	CcSEcCtD
Perphenazine—Diarrhoea—Glipizide—type 2 diabetes mellitus	9.96e-05	0.000986	CcSEcCtD
Perphenazine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000986	CcSEcCtD
Perphenazine—Muscle spasms—Metformin—type 2 diabetes mellitus	9.91e-05	0.000982	CcSEcCtD
Perphenazine—Cough—Valsartan—type 2 diabetes mellitus	9.88e-05	0.000979	CcSEcCtD
Perphenazine—Tachycardia—Gliclazide—type 2 diabetes mellitus	9.82e-05	0.000972	CcSEcCtD
Perphenazine—Jaundice—Ramipril—type 2 diabetes mellitus	9.8e-05	0.00097	CcSEcCtD
Perphenazine—Cough—Orlistat—type 2 diabetes mellitus	9.76e-05	0.000967	CcSEcCtD
Perphenazine—Decreased appetite—Glyburide—type 2 diabetes mellitus	9.74e-05	0.000964	CcSEcCtD
Perphenazine—Urticaria—Bromocriptine—type 2 diabetes mellitus	9.74e-05	0.000964	CcSEcCtD
Perphenazine—Erythema—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000964	CcSEcCtD
Perphenazine—Vision blurred—Metformin—type 2 diabetes mellitus	9.72e-05	0.000962	CcSEcCtD
Perphenazine—Convulsion—Orlistat—type 2 diabetes mellitus	9.7e-05	0.00096	CcSEcCtD
Perphenazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	9.69e-05	0.000959	CcSEcCtD
Perphenazine—Dizziness—Glipizide—type 2 diabetes mellitus	9.63e-05	0.000953	CcSEcCtD
Perphenazine—Pruritus—Glimepiride—type 2 diabetes mellitus	9.61e-05	0.000952	CcSEcCtD
Perphenazine—Promethazine—CALM1—type 2 diabetes mellitus	9.57e-05	0.0324	CrCbGaD
Perphenazine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	9.54e-05	0.000945	CcSEcCtD
Perphenazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	9.44e-05	0.0319	CrCbGaD
Perphenazine—Dry mouth—Valsartan—type 2 diabetes mellitus	9.43e-05	0.000934	CcSEcCtD
Perphenazine—Hypotension—Gliclazide—type 2 diabetes mellitus	9.4e-05	0.000931	CcSEcCtD
Perphenazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000929	CcSEcCtD
Perphenazine—HTR2A—liver—type 2 diabetes mellitus	9.38e-05	0.00248	CbGeAlD
Perphenazine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	9.36e-05	0.000927	CcSEcCtD
Perphenazine—Dry mouth—Orlistat—type 2 diabetes mellitus	9.32e-05	0.000923	CcSEcCtD
Perphenazine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	9.29e-05	0.00092	CcSEcCtD
Perphenazine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	9.26e-05	0.000917	CcSEcCtD
Perphenazine—Syncope—Metformin—type 2 diabetes mellitus	9.25e-05	0.000916	CcSEcCtD
Perphenazine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	9.24e-05	0.000915	CcSEcCtD
Perphenazine—Dizziness—Pioglitazone—type 2 diabetes mellitus	9.22e-05	0.000913	CcSEcCtD
Perphenazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	9.22e-05	0.0312	CrCbGaD
Perphenazine—Infection—Valsartan—type 2 diabetes mellitus	9.18e-05	0.000909	CcSEcCtD
Perphenazine—Vision blurred—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000908	CcSEcCtD
Perphenazine—Erythema—Losartan—type 2 diabetes mellitus	9.16e-05	0.000907	CcSEcCtD
Perphenazine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	9.13e-05	0.000904	CcSEcCtD
Perphenazine—Headache—Glipizide—type 2 diabetes mellitus	9.12e-05	0.000903	CcSEcCtD
Perphenazine—Insomnia—Gliclazide—type 2 diabetes mellitus	9.1e-05	0.000901	CcSEcCtD
Perphenazine—Shock—Valsartan—type 2 diabetes mellitus	9.09e-05	0.0009	CcSEcCtD
Perphenazine—Infection—Orlistat—type 2 diabetes mellitus	9.07e-05	0.000898	CcSEcCtD
Perphenazine—Loss of consciousness—Metformin—type 2 diabetes mellitus	9.06e-05	0.000898	CcSEcCtD
Perphenazine—Dizziness—Glimepiride—type 2 diabetes mellitus	8.98e-05	0.00089	CcSEcCtD
Perphenazine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	8.97e-05	0.000888	CcSEcCtD
Perphenazine—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.95e-05	0.000887	CcSEcCtD
Perphenazine—Agitation—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000886	CcSEcCtD
Perphenazine—Somnolence—Gliclazide—type 2 diabetes mellitus	8.94e-05	0.000886	CcSEcCtD
Perphenazine—Hypertension—Metformin—type 2 diabetes mellitus	8.9e-05	0.000882	CcSEcCtD
Perphenazine—Urticaria—Glyburide—type 2 diabetes mellitus	8.9e-05	0.000881	CcSEcCtD
Perphenazine—Angioedema—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000881	CcSEcCtD
Perphenazine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	8.89e-05	0.00088	CcSEcCtD
Perphenazine—Anorexia—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000872	CcSEcCtD
Perphenazine—Muscle spasms—Losartan—type 2 diabetes mellitus	8.81e-05	0.000872	CcSEcCtD
Perphenazine—Headache—Pioglitazone—type 2 diabetes mellitus	8.74e-05	0.000865	CcSEcCtD
Perphenazine—Syncope—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000864	CcSEcCtD
Perphenazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000863	CcSEcCtD
Perphenazine—CYP3A4—liver—type 2 diabetes mellitus	8.68e-05	0.00229	CbGeAlD
Perphenazine—Hypotension—Valsartan—type 2 diabetes mellitus	8.64e-05	0.000855	CcSEcCtD
Perphenazine—Vision blurred—Losartan—type 2 diabetes mellitus	8.63e-05	0.000855	CcSEcCtD
Perphenazine—Constipation—Gliclazide—type 2 diabetes mellitus	8.6e-05	0.000852	CcSEcCtD
Perphenazine—Pain—Gliclazide—type 2 diabetes mellitus	8.6e-05	0.000852	CcSEcCtD
Perphenazine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000847	CcSEcCtD
Perphenazine—CYP2D6—liver—type 2 diabetes mellitus	8.54e-05	0.00226	CbGeAlD
Perphenazine—Headache—Glimepiride—type 2 diabetes mellitus	8.51e-05	0.000843	CcSEcCtD
Perphenazine—Cough—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.000841	CcSEcCtD
Perphenazine—Headache—Sitagliptin—type 2 diabetes mellitus	8.48e-05	0.00084	CcSEcCtD
Perphenazine—Agitation—Losartan—type 2 diabetes mellitus	8.42e-05	0.000833	CcSEcCtD
Perphenazine—Hypertension—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000832	CcSEcCtD
Perphenazine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.38e-05	0.00083	CcSEcCtD
Perphenazine—Angioedema—Losartan—type 2 diabetes mellitus	8.37e-05	0.000829	CcSEcCtD
Perphenazine—Infection—Metformin—type 2 diabetes mellitus	8.36e-05	0.000828	CcSEcCtD
Perphenazine—Insomnia—Valsartan—type 2 diabetes mellitus	8.36e-05	0.000828	CcSEcCtD
Perphenazine—Shock—Metformin—type 2 diabetes mellitus	8.28e-05	0.00082	CcSEcCtD
Perphenazine—Insomnia—Orlistat—type 2 diabetes mellitus	8.26e-05	0.000818	CcSEcCtD
Perphenazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.25e-05	0.000817	CcSEcCtD
Perphenazine—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.24e-05	0.000816	CcSEcCtD
Perphenazine—Somnolence—Valsartan—type 2 diabetes mellitus	8.22e-05	0.000814	CcSEcCtD
Perphenazine—Syncope—Losartan—type 2 diabetes mellitus	8.21e-05	0.000813	CcSEcCtD
Perphenazine—Leukopenia—Losartan—type 2 diabetes mellitus	8.2e-05	0.000812	CcSEcCtD
Perphenazine—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.1e-05	0.000802	CcSEcCtD
Perphenazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000802	CcSEcCtD
Perphenazine—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.05e-05	0.000797	CcSEcCtD
Perphenazine—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.03e-05	0.000796	CcSEcCtD
Perphenazine—Anorexia—Metformin—type 2 diabetes mellitus	8.02e-05	0.000794	CcSEcCtD
Perphenazine—Cough—Losartan—type 2 diabetes mellitus	7.99e-05	0.000791	CcSEcCtD
Perphenazine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.99e-05	0.000791	CcSEcCtD
Perphenazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.95e-05	0.000787	CcSEcCtD
Perphenazine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.000786	CcSEcCtD
Perphenazine—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.94e-05	0.000786	CcSEcCtD
Perphenazine—Pruritus—Glyburide—type 2 diabetes mellitus	7.93e-05	0.000785	CcSEcCtD
Perphenazine—Constipation—Valsartan—type 2 diabetes mellitus	7.9e-05	0.000783	CcSEcCtD
Perphenazine—Infection—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000781	CcSEcCtD
Perphenazine—Hypotension—Metformin—type 2 diabetes mellitus	7.86e-05	0.000779	CcSEcCtD
Perphenazine—Erythema—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000778	CcSEcCtD
Perphenazine—Shock—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000774	CcSEcCtD
Perphenazine—Pain—Orlistat—type 2 diabetes mellitus	7.81e-05	0.000773	CcSEcCtD
Perphenazine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000768	CcSEcCtD
Perphenazine—Headache—Bromocriptine—type 2 diabetes mellitus	7.68e-05	0.00076	CcSEcCtD
Perphenazine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.67e-05	0.000759	CcSEcCtD
Perphenazine—Dry mouth—Losartan—type 2 diabetes mellitus	7.63e-05	0.000755	CcSEcCtD
Perphenazine—Anorexia—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.00075	CcSEcCtD
Perphenazine—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000748	CcSEcCtD
Perphenazine—Confusional state—Losartan—type 2 diabetes mellitus	7.54e-05	0.000746	CcSEcCtD
Perphenazine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.5e-05	0.000743	CcSEcCtD
Perphenazine—Somnolence—Metformin—type 2 diabetes mellitus	7.48e-05	0.000741	CcSEcCtD
Perphenazine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.47e-05	0.00074	CcSEcCtD
Perphenazine—Infection—Losartan—type 2 diabetes mellitus	7.43e-05	0.000735	CcSEcCtD
Perphenazine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000735	CcSEcCtD
Perphenazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.41e-05	0.000734	CcSEcCtD
Perphenazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	7.41e-05	0.0251	CrCbGaD
Perphenazine—Shock—Losartan—type 2 diabetes mellitus	7.35e-05	0.000728	CcSEcCtD
Perphenazine—Urticaria—Valsartan—type 2 diabetes mellitus	7.34e-05	0.000727	CcSEcCtD
Perphenazine—Decreased appetite—Metformin—type 2 diabetes mellitus	7.32e-05	0.000724	CcSEcCtD
Perphenazine—Tachycardia—Losartan—type 2 diabetes mellitus	7.3e-05	0.000722	CcSEcCtD
Perphenazine—Urticaria—Orlistat—type 2 diabetes mellitus	7.25e-05	0.000718	CcSEcCtD
Perphenazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000715	CcSEcCtD
Perphenazine—Agitation—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000715	CcSEcCtD
Perphenazine—Constipation—Metformin—type 2 diabetes mellitus	7.2e-05	0.000713	CcSEcCtD
Perphenazine—Angioedema—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000711	CcSEcCtD
Perphenazine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	7.17e-05	0.0243	CrCbGaD
Perphenazine—Nefazodone—ADRA2A—type 2 diabetes mellitus	7.13e-05	0.0241	CrCbGaD
Perphenazine—Anorexia—Losartan—type 2 diabetes mellitus	7.12e-05	0.000706	CcSEcCtD
Perphenazine—Pruritus—Gliclazide—type 2 diabetes mellitus	7.12e-05	0.000705	CcSEcCtD
Perphenazine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000701	CcSEcCtD
Perphenazine—Somnolence—Irbesartan—type 2 diabetes mellitus	7.06e-05	0.000699	CcSEcCtD
Perphenazine—Syncope—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000697	CcSEcCtD
Perphenazine—Leukopenia—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000696	CcSEcCtD
Perphenazine—Headache—Glyburide—type 2 diabetes mellitus	7.02e-05	0.000695	CcSEcCtD
Perphenazine—Hypotension—Losartan—type 2 diabetes mellitus	6.98e-05	0.000692	CcSEcCtD
Perphenazine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000684	CcSEcCtD
Perphenazine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000683	CcSEcCtD
Perphenazine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.88e-05	0.000682	CcSEcCtD
Perphenazine—Cough—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000679	CcSEcCtD
Perphenazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.81e-05	0.000674	CcSEcCtD
Perphenazine—Convulsion—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000674	CcSEcCtD
Perphenazine—Pain—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000673	CcSEcCtD
Perphenazine—Constipation—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000673	CcSEcCtD
Perphenazine—Insomnia—Losartan—type 2 diabetes mellitus	6.76e-05	0.000669	CcSEcCtD
Perphenazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.73e-05	0.000666	CcSEcCtD
Perphenazine—Urticaria—Metformin—type 2 diabetes mellitus	6.69e-05	0.000662	CcSEcCtD
Perphenazine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.66e-05	0.00066	CcSEcCtD
Perphenazine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.65e-05	0.000659	CcSEcCtD
Perphenazine—Somnolence—Losartan—type 2 diabetes mellitus	6.64e-05	0.000658	CcSEcCtD
Perphenazine—Aripiprazole—ADRA2A—type 2 diabetes mellitus	6.63e-05	0.0224	CrCbGaD
Perphenazine—Trazodone—ADRA2A—type 2 diabetes mellitus	6.6e-05	0.0223	CrCbGaD
Perphenazine—Nefazodone—HTR2C—type 2 diabetes mellitus	6.57e-05	0.0222	CrCbGaD
Perphenazine—Pruritus—Valsartan—type 2 diabetes mellitus	6.54e-05	0.000647	CcSEcCtD
Perphenazine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000647	CcSEcCtD
Perphenazine—Decreased appetite—Losartan—type 2 diabetes mellitus	6.5e-05	0.000643	CcSEcCtD
Perphenazine—Confusional state—Ramipril—type 2 diabetes mellitus	6.46e-05	0.00064	CcSEcCtD
Perphenazine—Pruritus—Orlistat—type 2 diabetes mellitus	6.46e-05	0.00064	CcSEcCtD
Perphenazine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000635	CcSEcCtD
Perphenazine—Constipation—Losartan—type 2 diabetes mellitus	6.39e-05	0.000633	CcSEcCtD
Perphenazine—Pain—Losartan—type 2 diabetes mellitus	6.39e-05	0.000633	CcSEcCtD
Perphenazine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.32e-05	0.000626	CcSEcCtD
Perphenazine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.000625	CcSEcCtD
Perphenazine—Shock—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000624	CcSEcCtD
Perphenazine—Headache—Gliclazide—type 2 diabetes mellitus	6.3e-05	0.000624	CcSEcCtD
Perphenazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000622	CcSEcCtD
Perphenazine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000619	CcSEcCtD
Perphenazine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.25e-05	0.000619	CcSEcCtD
Perphenazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	6.18e-05	0.0209	CrCbGaD
Perphenazine—Dizziness—Valsartan—type 2 diabetes mellitus	6.11e-05	0.000605	CcSEcCtD
Perphenazine—Anorexia—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000605	CcSEcCtD
Perphenazine—Aripiprazole—HTR2C—type 2 diabetes mellitus	6.1e-05	0.0206	CrCbGaD
Perphenazine—Trazodone—HTR2C—type 2 diabetes mellitus	6.08e-05	0.0205	CrCbGaD
Perphenazine—Dizziness—Orlistat—type 2 diabetes mellitus	6.04e-05	0.000598	CcSEcCtD
Perphenazine—Hypotension—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000593	CcSEcCtD
Perphenazine—Domperidone—CYP1A2—type 2 diabetes mellitus	5.97e-05	0.0202	CrCbGaD
Perphenazine—Pruritus—Metformin—type 2 diabetes mellitus	5.95e-05	0.00059	CcSEcCtD
Perphenazine—Urticaria—Losartan—type 2 diabetes mellitus	5.94e-05	0.000588	CcSEcCtD
Perphenazine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.91e-05	0.000585	CcSEcCtD
Perphenazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000579	CcSEcCtD
Perphenazine—Insomnia—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000574	CcSEcCtD
Perphenazine—Headache—Valsartan—type 2 diabetes mellitus	5.79e-05	0.000573	CcSEcCtD
Perphenazine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.76e-05	0.00057	CcSEcCtD
Perphenazine—Headache—Orlistat—type 2 diabetes mellitus	5.72e-05	0.000567	CcSEcCtD
Perphenazine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000566	CcSEcCtD
Perphenazine—Somnolence—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000564	CcSEcCtD
Perphenazine—Thiothixene—HTR2C—type 2 diabetes mellitus	5.69e-05	0.0193	CrCbGaD
Perphenazine—Pruritus—Irbesartan—type 2 diabetes mellitus	5.62e-05	0.000556	CcSEcCtD
Perphenazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	5.62e-05	0.019	CrCbGaD
Perphenazine—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000552	CcSEcCtD
Perphenazine—Dizziness—Metformin—type 2 diabetes mellitus	5.57e-05	0.000551	CcSEcCtD
Perphenazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.51e-05	0.000545	CcSEcCtD
Perphenazine—Constipation—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000543	CcSEcCtD
Perphenazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	5.44e-05	0.0184	CrCbGaD
Perphenazine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000538	CcSEcCtD
Perphenazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	5.34e-05	0.0181	CrCbGaD
Perphenazine—Pruritus—Losartan—type 2 diabetes mellitus	5.29e-05	0.000524	CcSEcCtD
Perphenazine—Headache—Metformin—type 2 diabetes mellitus	5.27e-05	0.000522	CcSEcCtD
Perphenazine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.25e-05	0.00052	CcSEcCtD
Perphenazine—Diarrhoea—Losartan—type 2 diabetes mellitus	5.11e-05	0.000506	CcSEcCtD
Perphenazine—Urticaria—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000504	CcSEcCtD
Perphenazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000502	CcSEcCtD
Perphenazine—Headache—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000493	CcSEcCtD
Perphenazine—Dizziness—Losartan—type 2 diabetes mellitus	4.94e-05	0.000489	CcSEcCtD
Perphenazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	4.92e-05	0.0166	CrCbGaD
Perphenazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	4.89e-05	0.0165	CrCbGaD
Perphenazine—Propiomazine—HTR2C—type 2 diabetes mellitus	4.73e-05	0.016	CrCbGaD
Perphenazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000468	CcSEcCtD
Perphenazine—Headache—Losartan—type 2 diabetes mellitus	4.68e-05	0.000464	CcSEcCtD
Perphenazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	4.64e-05	0.0157	CrCbGaD
Perphenazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	4.61e-05	0.0156	CrCbGaD
Perphenazine—Pruritus—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000449	CcSEcCtD
Perphenazine—Clomipramine—HTR2C—type 2 diabetes mellitus	4.5e-05	0.0152	CrCbGaD
Perphenazine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	4.48e-05	0.0152	CrCbGaD
Perphenazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	4.4e-05	0.0149	CrCbGaD
Perphenazine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000434	CcSEcCtD
Perphenazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	4.3e-05	0.0145	CrCbGaD
Perphenazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	4.3e-05	0.0145	CrCbGaD
Perphenazine—Thioridazine—HTR2C—type 2 diabetes mellitus	4.24e-05	0.0143	CrCbGaD
Perphenazine—Dizziness—Ramipril—type 2 diabetes mellitus	4.24e-05	0.00042	CcSEcCtD
Perphenazine—Quetiapine—ADRA2A—type 2 diabetes mellitus	4.14e-05	0.014	CrCbGaD
Perphenazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	4.05e-05	0.0137	CrCbGaD
Perphenazine—Headache—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000398	CcSEcCtD
Perphenazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	4e-05	0.0135	CrCbGaD
Perphenazine—Domperidone—CYP3A4—type 2 diabetes mellitus	3.95e-05	0.0134	CrCbGaD
Perphenazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	3.93e-05	0.0133	CrCbGaD
Perphenazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	3.9e-05	0.0132	CrCbGaD
Perphenazine—Quetiapine—HTR2C—type 2 diabetes mellitus	3.82e-05	0.0129	CrCbGaD
Perphenazine—Promazine—ADRA2A—type 2 diabetes mellitus	3.81e-05	0.0129	CrCbGaD
Perphenazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	3.71e-05	0.0126	CrCbGaD
Perphenazine—Promazine—HTR2C—type 2 diabetes mellitus	3.51e-05	0.0119	CrCbGaD
Perphenazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	3.4e-05	0.0115	CrCbGaD
Perphenazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	3.36e-05	0.0114	CrCbGaD
Perphenazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	3.35e-05	0.0113	CrCbGaD
Perphenazine—Nefazodone—CYP3A4—type 2 diabetes mellitus	3.28e-05	0.0111	CrCbGaD
Perphenazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	3.21e-05	0.0109	CrCbGaD
Perphenazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	3.2e-05	0.0108	CrCbGaD
Perphenazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	3.09e-05	0.0104	CrCbGaD
Perphenazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	3.05e-05	0.0103	CrCbGaD
Perphenazine—Aripiprazole—CYP3A4—type 2 diabetes mellitus	3.05e-05	0.0103	CrCbGaD
Perphenazine—Trazodone—CYP3A4—type 2 diabetes mellitus	3.03e-05	0.0103	CrCbGaD
Perphenazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	2.97e-05	0.01	CrCbGaD
Perphenazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	2.84e-05	0.00962	CrCbGaD
Perphenazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	2.72e-05	0.00919	CrCbGaD
Perphenazine—Promazine—CYP1A2—type 2 diabetes mellitus	2.65e-05	0.00895	CrCbGaD
Perphenazine—Acepromazine—ALB—type 2 diabetes mellitus	2.58e-05	0.00873	CrCbGaD
Perphenazine—Thioproperazine—ALB—type 2 diabetes mellitus	2.52e-05	0.00853	CrCbGaD
Perphenazine—Thiothixene—ALB—type 2 diabetes mellitus	2.48e-05	0.00839	CrCbGaD
Perphenazine—Pipotiazine—ALB—type 2 diabetes mellitus	2.48e-05	0.00839	CrCbGaD
Perphenazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	2.45e-05	0.00828	CrCbGaD
Perphenazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	2.33e-05	0.00788	CrCbGaD
Perphenazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	2.25e-05	0.0076	CrCbGaD
Perphenazine—Clomipramine—ALB—type 2 diabetes mellitus	1.96e-05	0.00663	CrCbGaD
Perphenazine—Quetiapine—CYP3A4—type 2 diabetes mellitus	1.91e-05	0.00645	CrCbGaD
Perphenazine—Promazine—CYP3A4—type 2 diabetes mellitus	1.75e-05	0.00593	CrCbGaD
Perphenazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	1.54e-05	0.00521	CrCbGaD
Perphenazine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.35e-05	0.00455	CrCbGaD
Perphenazine—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	1.11e-06	1.27e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.11e-06	1.27e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-06	1.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.09e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.09e-06	1.25e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-06	1.25e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.09e-06	1.25e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-06	1.25e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.08e-06	1.25e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-06	1.24e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—SRC—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—SRC—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.07e-06	1.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.06e-06	1.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.06e-06	1.22e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.06e-06	1.22e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	1.06e-06	1.22e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.06e-06	1.21e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.05e-06	1.2e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-06	1.2e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.04e-06	1.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.04e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.04e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.03e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.03e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.03e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—SRC—type 2 diabetes mellitus	1.03e-06	1.18e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.02e-06	1.17e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.02e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.02e-06	1.17e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.01e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.01e-06	1.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.01e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.01e-06	1.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1e-06	1.15e-05	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1e-06	1.15e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1e-06	1.15e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1e-06	1.15e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1e-06	1.15e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	9.96e-07	1.14e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.93e-07	1.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—SRC—type 2 diabetes mellitus	9.92e-07	1.14e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—SRC—type 2 diabetes mellitus	9.92e-07	1.14e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.91e-07	1.14e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	9.88e-07	1.14e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.86e-07	1.13e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.84e-07	1.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.84e-07	1.13e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.84e-07	1.13e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.75e-07	1.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	9.73e-07	1.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.71e-07	1.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.71e-07	1.12e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.7e-07	1.11e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	9.64e-07	1.11e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	9.57e-07	1.1e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	9.56e-07	1.1e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.54e-07	1.1e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	9.48e-07	1.09e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.48e-07	1.09e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	9.45e-07	1.09e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	9.44e-07	1.08e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.43e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	9.42e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	9.42e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	9.42e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	9.41e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.39e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.39e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.39e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.39e-07	1.08e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.38e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	9.38e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	9.37e-07	1.08e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.36e-07	1.08e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	9.31e-07	1.07e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.28e-07	1.07e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	9.27e-07	1.07e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.26e-07	1.06e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.25e-07	1.06e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	9.24e-07	1.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	9.17e-07	1.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.14e-07	1.05e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.12e-07	1.05e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	9.11e-07	1.05e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	9.1e-07	1.05e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.1e-07	1.05e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.08e-07	1.04e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	9.04e-07	1.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.03e-07	1.04e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	9.01e-07	1.04e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	9.01e-07	1.04e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—type 2 diabetes mellitus	8.99e-07	1.03e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.97e-07	1.03e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.95e-07	1.03e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.9e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	8.87e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	8.87e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	8.84e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.84e-07	1.02e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	8.79e-07	1.01e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.79e-07	1.01e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.78e-07	1.01e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.73e-07	1e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—type 2 diabetes mellitus	8.69e-07	9.99e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—type 2 diabetes mellitus	8.69e-07	9.99e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	8.67e-07	9.96e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.65e-07	9.94e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	8.63e-07	9.92e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.63e-07	9.92e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	8.59e-07	9.87e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.56e-07	9.84e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.54e-07	9.81e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	8.45e-07	9.71e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.45e-07	9.71e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.42e-07	9.68e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	8.42e-07	9.68e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.41e-07	9.66e-06	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.41e-07	9.66e-06	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.4e-07	9.65e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.29e-07	9.53e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.29e-07	9.53e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.28e-07	9.51e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	8.24e-07	9.47e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.24e-07	9.47e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	8.22e-07	9.45e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	8.22e-07	9.45e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	8.2e-07	9.43e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.19e-07	9.41e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	8.17e-07	9.38e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.1e-07	9.31e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	8.01e-07	9.2e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.97e-07	9.16e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.97e-07	9.16e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.92e-07	9.1e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.92e-07	9.1e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.87e-07	9.04e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.86e-07	9.03e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.84e-07	9.01e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.79e-07	8.95e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.77e-07	8.93e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.73e-07	8.89e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.72e-07	8.87e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.71e-07	8.86e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.71e-07	8.86e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.66e-07	8.81e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	7.62e-07	8.76e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	7.58e-07	8.71e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.58e-07	8.71e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.57e-07	8.69e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.55e-07	8.68e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.53e-07	8.66e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.53e-07	8.66e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	7.52e-07	8.64e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—type 2 diabetes mellitus	7.48e-07	8.6e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.45e-07	8.57e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.45e-07	8.57e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	7.38e-07	8.49e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	7.34e-07	8.44e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.31e-07	8.4e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.31e-07	8.4e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.26e-07	8.34e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—type 2 diabetes mellitus	7.24e-07	8.32e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—type 2 diabetes mellitus	7.24e-07	8.32e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.24e-07	8.32e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.24e-07	8.32e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.18e-07	8.25e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.15e-07	8.22e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.03e-07	8.08e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.02e-07	8.07e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.02e-07	8.07e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.99e-07	8.04e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.95e-07	7.98e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.95e-07	7.98e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—type 2 diabetes mellitus	6.91e-07	7.94e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	6.9e-07	7.93e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.9e-07	7.93e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.77e-07	7.77e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.77e-07	7.77e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.74e-07	7.75e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.71e-07	7.71e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—type 2 diabetes mellitus	6.68e-07	7.68e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—type 2 diabetes mellitus	6.68e-07	7.68e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	6.68e-07	7.67e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	6.68e-07	7.67e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	6.42e-07	7.38e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.42e-07	7.38e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—type 2 diabetes mellitus	6.37e-07	7.32e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.3e-07	7.24e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.29e-07	7.23e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.22e-07	7.15e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.21e-07	7.14e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.21e-07	7.14e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.19e-07	7.11e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.18e-07	7.1e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—type 2 diabetes mellitus	6.16e-07	7.08e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—type 2 diabetes mellitus	6.16e-07	7.08e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.09e-07	7e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.09e-07	7e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.92e-07	6.81e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	5.85e-07	6.72e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.83e-07	6.7e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.81e-07	6.68e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.67e-07	6.51e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	5.48e-07	6.3e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.46e-07	6.28e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.42e-07	6.23e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.42e-07	6.23e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.38e-07	6.18e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.36e-07	6.16e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	5.34e-07	6.13e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.3e-07	6.09e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	5.16e-07	5.93e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	5.16e-07	5.93e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.96e-07	5.7e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.89e-07	5.62e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.84e-07	5.56e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.68e-07	5.38e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.68e-07	5.38e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	4.64e-07	5.33e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.46e-07	5.13e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.32e-07	4.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.32e-07	4.96e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	4.14e-07	4.76e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.81e-07	4.38e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.78e-07	4.34e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.23e-07	3.71e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.49e-07	2.86e-06	CbGpPWpGaD
